Confluence Wealth Services, Inc.

Position in VTGN — Vistagen Therapeutics, Inc.

CIK 1910411 MCMURRAY, PA

Position in VTGN

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$7,500

New position

Shares Held

32,610

first reported quarter

Ownership

0.079%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1

of 4 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Confluence Wealth Services, Inc. holds $2,485,829 across 5 Biotechnology names. VTGN ranks #5 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	3,792	$1,409,372
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,642	$815,630
3	DFTX	Definium Therapeutics, Inc.	4,796	$225,603
4	CHRS	Coherus Oncology, Inc.	19,803	$27,724
5	VTGN	Vistagen Therapeutics, Inc. This page	32,610	$7,500

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,500	32,610	—	Shares	Sole	2026-07-22
No filing history on record for this holder in this stock.